Five parallel groups, exploratory clinical trial to compare the efficacy of single dose levocetirizine 2.5 and 5 mg, cetirizine 5 mg and 10 mg to placebo in reducing symptoms of SAR [seasonal allergic rhinitis] in sensitive subjects exposed to ragweed pollen in a EEU [environmental exposure chamber].
Phase of Trial: Phase II
Latest Information Update: 15 Feb 2017
At a glance
- Drugs Levocetirizine (Primary) ; Cetirizine
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors UCB
- 06 Jun 2007 Status change from in progress to completed.
- 30 Sep 2006 New trial record.